Search research articles
Contact Us
Filters
Showing results (341-350 of 390) with videos related to
Page
of 39
Sort By:
Journal of the American College of Cardiology
|
May 12, 2012
Plasma PCSK9 levels and clinical outcomes in the TNT (Treating to New Targets) trial: a nested case-control study
Roeland Huijgen, S Matthijs Boekholdt, Benoit J Arsenault, et al.
Annals of the Rheumatic Diseases
|
February 9, 2008
Differential Toll-like receptor-dependent collagenase expression in chondrocytes
Q Zhang, W Hui, G J Litherland, et al.
Journal of the American College of Cardiology
|
March 14, 2009
Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes
Sanjay Patel, Brian G Drew, Shirley Nakhla, et al.
Diabetologia
|
May 20, 2016
In vivo PET imaging with [(18)F]FDG to explain improved glucose uptake in an apolipoprotein A-I treated mouse model of diabetes
Blake J Cochran, William J Ryder, Arvind Parmar, et al.
Metabolism: Clinical and Experimental
|
November 20, 2018
High plasma FGF21 levels predicts major cardiovascular events in patients treated with atorvastatin (from the Treating to New Targets [TNT] Study)
Kwok Leung Ong, Nicholas Hui, Andrzej S Januszewski, et al.
Diabetologia
|
June 10, 2015
Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study
Kwok-Leung Ong, Andrzej S Januszewski, Rachel O'Connell, et al.
European Heart Journal
|
May 7, 2013
Factors underlying regression of coronary atheroma with potent statin therapy
Rishi Puri, Steven E Nissen, Christie M Ballantyne, et al.
European Heart Journal. Cardiovascular Imaging
|
January 23, 2014
Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN
Rishi Puri, Peter Libby, Steven E Nissen, et al.
Diabetes Care
|
September 6, 2014
High-intensity statin therapy alters the natural history of diabetic coronary atherosclerosis: insights from SATURN
Brian Stegman, Rishi Puri, Leslie Cho, et al.
JAMA Cardiology
|
October 27, 2017
Association of Lipoprotein(a) With Risk of Recurrent Ischemic Events Following Acute Coronary Syndrome: Analysis of the dal-Outcomes Randomized Clinical Trial
Gregory G Schwartz, Christie M Ballantyne, Philip J Barter, et al.
Page
of 39
Search research articles
Search
Showing results (341-350 of 390) with videos related to
Sort By:
Page
of 39
Journal of the American College of Cardiology
|
May 12, 2012
Plasma PCSK9 levels and clinical outcomes in the TNT (Treating to New Targets) trial: a nested case-control study
Roeland Huijgen, S Matthijs Boekholdt, Benoit J Arsenault, et al.
Annals of the Rheumatic Diseases
|
February 9, 2008
Differential Toll-like receptor-dependent collagenase expression in chondrocytes
Q Zhang, W Hui, G J Litherland, et al.
Journal of the American College of Cardiology
|
March 14, 2009
Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes
Sanjay Patel, Brian G Drew, Shirley Nakhla, et al.
Diabetologia
|
May 20, 2016
In vivo PET imaging with [(18)F]FDG to explain improved glucose uptake in an apolipoprotein A-I treated mouse model of diabetes
Blake J Cochran, William J Ryder, Arvind Parmar, et al.
Metabolism: Clinical and Experimental
|
November 20, 2018
High plasma FGF21 levels predicts major cardiovascular events in patients treated with atorvastatin (from the Treating to New Targets [TNT] Study)
Kwok Leung Ong, Nicholas Hui, Andrzej S Januszewski, et al.
Diabetologia
|
June 10, 2015
Relationship of fibroblast growth factor 21 with baseline and new on-study microvascular disease in the Fenofibrate Intervention and Event Lowering in Diabetes study
Kwok-Leung Ong, Andrzej S Januszewski, Rachel O'Connell, et al.
European Heart Journal
|
May 7, 2013
Factors underlying regression of coronary atheroma with potent statin therapy
Rishi Puri, Steven E Nissen, Christie M Ballantyne, et al.
European Heart Journal. Cardiovascular Imaging
|
January 23, 2014
Long-term effects of maximally intensive statin therapy on changes in coronary atheroma composition: insights from SATURN
Rishi Puri, Peter Libby, Steven E Nissen, et al.
Diabetes Care
|
September 6, 2014
High-intensity statin therapy alters the natural history of diabetic coronary atherosclerosis: insights from SATURN
Brian Stegman, Rishi Puri, Leslie Cho, et al.
JAMA Cardiology
|
October 27, 2017
Association of Lipoprotein(a) With Risk of Recurrent Ischemic Events Following Acute Coronary Syndrome: Analysis of the dal-Outcomes Randomized Clinical Trial
Gregory G Schwartz, Christie M Ballantyne, Philip J Barter, et al.
Page
of 39